Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre‐existing cellular response to peptide
Authors:
Open Access
- 1 September 2003
- journal article
- clinical trial
- Published by Wiley in Cancer Science
- Vol. 94 (9) , 802-808
Abstract
There is no standard treatment modality for advanced gastric cancer (GC) at the present time. To develop a new treatment modality, we investigated the immunological responses of advanced GC patients (n=13, 9 non‐scirrhous and 4 scirrhous types) vaccinated with peptides to a regimen under which pre‐vaccination peripheral blood mononuclear cells (PBMCs) were screened for their reactivity in vitro to each of 14 peptides on HLA‐A24 or 16 peptides on ‐A2 allele, then only the reactive peptides (maximum: 4) were administered in vivo. This regimen was generally well tolerated, although grade I levels of fever and local skin reactions were observed in several patients. Delayed‐type hypersensitivity (DTH) to the vaccinated peptides was observed in 4 patients. Increased cellular and humoral immune responses to the vaccinated peptides were observed in post‐vaccination PBMCs from 4 of 8 patients and in post‐vaccination sera of 8 of 10 patients tested, respectively. Prolonged survival was observed in patients showing cellular and humoral immune responses to the vaccinated peptides in the post‐vaccination samples, including all 4 patients with the scirrhous type. These results encourage further development of peptide‐based immunotherapy for GC patients.Keywords
This publication has 11 references indexed in Scilit:
- Peptide Vaccination for Patients With Melanoma and Other Types of Cancer Based on Pre-existing Peptide-Specific Cytotoxic T-Lymphocyte Precursors in the PeripheryJournal of Immunotherapy, 2003
- Immunological evaluation of CTL precursor‐oriented vaccines for advanced lung cancer patientsCancer Science, 2003
- IgG reactive to CTL‐directed epitopes of self‐antigens is either lacking or unbalanced in atopic dermatitis patientsTissue Antigens, 2003
- Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patientsBritish Journal of Cancer, 2002
- Phase 1 Clinical Study of Cyclophilin B Peptide Vaccine for Patients With Lung CancerJournal of Immunotherapy, 2002
- A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulationCancer Immunology, Immunotherapy, 2002
- Expression of SART3 Tumor-rejection Antigen in Gastric CancersJapanese Journal of Cancer Research, 2000
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaNature Medicine, 1998
- Clinicopathologic study of patients with Borrmann type iv gastric carcinomaJournal of Surgical Oncology, 1995
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.Journal of Experimental Medicine, 1988